AlphaQuest LLC Has $978,000 Holdings in GE HealthCare Technologies Inc. $GEHC

AlphaQuest LLC lessened its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 49.5% during the 2nd quarter, Holdings Channel.com reports. The firm owned 13,210 shares of the company’s stock after selling 12,941 shares during the quarter. AlphaQuest LLC’s holdings in GE HealthCare Technologies were worth $978,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. JPMorgan Chase & Co. lifted its position in shares of GE HealthCare Technologies by 49.9% during the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after buying an additional 1,711,963 shares during the period. Nuveen LLC bought a new position in shares of GE HealthCare Technologies during the 1st quarter worth approximately $77,058,000. Eminence Capital LP lifted its position in shares of GE HealthCare Technologies by 38.7% during the 1st quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock worth $146,822,000 after buying an additional 507,101 shares during the period. Homestead Advisers Corp lifted its position in shares of GE HealthCare Technologies by 92.7% during the 1st quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock worth $79,790,000 after buying an additional 475,500 shares during the period. Finally, Canada Pension Plan Investment Board lifted its position in shares of GE HealthCare Technologies by 15.2% during the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock worth $251,121,000 after buying an additional 409,636 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

GEHC has been the subject of several research analyst reports. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday, October 14th. Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a research report on Thursday, September 18th. Citigroup downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their price objective for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. BTIG Research lifted their price objective on GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a research report on Monday, October 13th. Finally, Barclays initiated coverage on GE HealthCare Technologies in a research report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price objective for the company. Six equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $85.20.

GE HealthCare Technologies Stock Up 1.1%

Shares of GE HealthCare Technologies stock opened at $78.14 on Friday. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The business has a fifty day simple moving average of $74.78 and a 200 day simple moving average of $72.53. The stock has a market cap of $35.68 billion, a PE ratio of 16.01, a price-to-earnings-growth ratio of 2.99 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same period in the previous year, the firm earned $1.00 earnings per share. The firm’s quarterly revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s payout ratio is 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.